Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis.

Bogatkevich, Galina S; Atanelishvili, Ilia; Bogatkevich, Andrew M; Silver, Richard M

Bogatkevich, Galina S; Atanelishvili, Ilia; Bogatkevich, Andrew M; Silver, Richard M.

Afiliação

Bogatkevich GS; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston.
Atanelishvili I; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston.
Bogatkevich AM; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, and College of Charleston (BSc Student), Charleston, South Carolina.
Silver RM; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston.

Arthritis Rheumatol ; 75(3): 438-448, 2023 03.

Article em En | MEDLINE | ID: mdl-36103378

Assuntos

Doenças Pulmonares Intersticiais; Fibrose Pulmonar; Esclerodermia Localizada; Escleroderma Sistêmico; Animais; Camundongos; Fibrose Pulmonar/complicações; Miofibroblastos/metabolismo; Escleroderma Sistêmico/patologia; Doenças Pulmonares Intersticiais/etiologia; Pulmão/patologia; Fibroblastos/metabolismo; Esclerodermia Localizada/complicações; Proteínas Correpressoras/metabolismo; Proteínas Correpressoras/farmacologia; Proteínas com Domínio LIM/metabolismo; Proteínas com Domínio LIM/farmacologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Esclerodermia Localizada / Escleroderma Sistêmico / Doenças Pulmonares Intersticiais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google